56:136 57 2016 28 5 18 21. 650-0046 6-9-1 650-0046 6-11-1 650-0046 6 10-1 2016 2 9 7 13 Hands-on 4 Meet the Expert. http://www.neurology-jp.org/sokaitiho/neuro2016/ 15,000 18,000 3,000 3,000 3,000 3,000 3,000 18,000 21,000 18,000 21,000 5,000 5,000 3,000 3,000 Travel Grant 1 3,000 1 Travel Grant Travel Grant. http://www.neurology-jp.org/sokaitiho/neuro2016/ http://www.neurology-jp.org/sokaitiho/neuro2016/subject/igakusei.html
56:137 6 http://www.neurology-jp.org/sokaitiho/neuro2016/subject/medical_staff.html 7.. http://www.neurology-jp.org/sokaitiho/neuro2016/ 8 http://www.neurology-jp.org/sokaitiho/neuro2016/ 9 http://www.neurology-jp.org/sokaitiho/neuro2016/ 10 770-8503 3 18-15 113-0034 31 21 TEL 03-3815-1080 FAX 03-3815-1931 57 102-8481 5-1 TEL 03-5216-5318 FAX 03-5216-5552 E-mail neuro57@congre.co.jp E E Stanley Fahn (The Neurological Institute of New York, Columbia University Medical Center, USA) Mark Hallett (Human Motor Control Section, NINDS, NIH, USA) E Austin Sumner (Department of Neurology at Louisiana State University Health Sciences Center in New Orleans, USA) E Raad Shakir (President of the World Federation of Neurology) Terrence Cascino (President of the American Academy of Neurology) 2015 2015 2015 Next-generation neurogenetics: cutting-edge strategies for understanding neurological disorders E Therapuetic strategies, mechanisms of spreading of α-synuclein, and biomarkers of Parkinson s disease E Disease Spectrum of TFG Mutation E
56:138 E X-linked Dystonia Parkinsonism E How to manage Stroke E Priorities in Neurology E 5 18 Myasthenia gravis: New insights and overview E Cutting edge of metabolic/heredirary neuropathies E 5 18 Biomarkers and progression of motor neuron disease E Current topics in myotonic dystrophy advance in disease mechanism and emerging clinical issues E Neuro-oncology update Roles of neurologists E Abnormal voluntary movement recent advances E 2015 100 MRI MSA 2015 Disruption of glia neuron assemblies in intractable neurological disorders E Acute treatment and secondary prevention of stroke: The breaking evidences E Recent advance of Clinical trials and treatment in progressive supranuclear palsy E Neuroregeneration and nucleic acid medicine E 3 AD DLB FTD Neuro CPC Combining imaging and therapy: Neuroimaging-based companion diagnostics and theranostics E Molecular dissection of Hereditary Spastic Paraplegia E Improvement in the management of Parkinson s disease: Present status and prospect of ultra-early diagnosis E subspecialty Understanding ALS pathogenesis by Updated progress in C9ORF72-TDP43 lineage E Expanding prion concept to cerebral beta-amyloidosis and alpha-synucleinopathies E Movement Disorders Video Session E
56:139 emerging concepts 202030 Pathomechanisms and therapeutic intervention of abnormal excitability in the upper and lower motor neuron systems E Current research for cure of MS and NMO E Gene therapy & regenerative medicine E 5 21 PSP/ CBD disease modifying therapy 5 21 PMDA Late Breaking Symposium 5 21
56:140
56:141
56:142
56:143
56:144